Yes, a 17-year-old can and should receive meningococcal vaccines
A 17-year-old should receive meningococcal vaccination according to the current ACIP guidelines, which recommend routine MenACWY vaccination for all adolescents aged 11-18 years, with a booster at age 16, and MenB vaccination for ages 16-23 years based on shared clinical decision-making (preferred age 16-18 years). 1
MenACWY Vaccination at Age 17
For a 17-year-old, the vaccination status depends on their prior immunization history:
- If they received their first MenACWY dose before age 16: They should receive a booster dose now at age 17 1
- If they received their first dose at age 16 or later: No additional dose is needed unless more than 5 years have elapsed 1
- If never vaccinated: They should receive at least one dose of MenACWY as catch-up vaccination 1
The 2024 ACIP schedule confirms that routine MenACWY vaccination is recommended for adolescents aged 11-18 years, placing 17-year-olds squarely within the recommended age range 2.
MenB Vaccination at Age 17
MenB vaccination is appropriate and recommended for 17-year-olds based on shared clinical decision-making, with the preferred age being 16-18 years 1. This means:
- The vaccine series consists of either:
- MenB vaccines are licensed for ages 10-25 years 1
- At age 17, the patient falls within both the licensed age range and the preferred vaccination window
Important Clinical Considerations
Common pitfall: The "shared clinical decision-making" language for MenB has led to confusion and lower uptake compared to MenACWY 3. This does NOT mean the vaccine is optional or less important—it means providers should discuss the benefits and risks with patients/parents and make an informed decision together. Given that serogroup B now causes an increasing proportion of adolescent meningococcal disease 4, this discussion should favor vaccination for most healthy adolescents.
Special circumstances requiring vaccination (not just shared decision-making):
- Persistent complement deficiencies
- Complement inhibitor use (eculizumab, ravulizumab)
- Anatomic or functional asplenia
- HIV infection
- Microbiologists routinely exposed to N. meningitidis
- During serogroup B outbreaks 1
Practical Implementation
For college-bound students: If the 17-year-old will be a college freshman living in residence halls, ensure they receive at least one dose of MenACWY within 5 years before college entry, preferably on or after their 16th birthday 1. Many colleges require meningococcal vaccination for enrollment.
Vaccine interchangeability: Different MenACWY products are interchangeable 1, but MenB products (MenB-FHbp and MenB-4C) are NOT interchangeable and the same product must be used for all doses in the series 1.
New pentavalent option: As of 2024-2025, pentavalent MenABCWY vaccines (covering all five serogroups) are now available and may be used when both MenACWY and MenB are indicated at the same visit 2, 5. This can simplify administration and potentially improve coverage rates.